(PLRX) Pliant Therapeutics - Performance -88.7% in 12m
PLRX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-83.93%
#150 in Peer-Group
Rel. Strength
1.40%
#7556 in Stock-Universe
Total Return 12m
-88.72%
#193 in Peer-Group
Total Return 5y
-93.79%
#144 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 15.70 USD |
| 52 Week Low | 1.16 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 82.31 |
| Buy/Sell Signal +-5 | 1.35 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: PLRX (-88.7%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: PLRX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PLRX
| Total Return (including Dividends) | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.42% | 3.15% | 4.01% |
| 3 Months | 5.22% | 17.08% | 17.14% |
| 12 Months | -88.72% | -11.14% | 13.46% |
| 5 Years | -93.79% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -34.4% | 52.1% | 90.3% |
| 3 Months | -48.8% | 79.4% | 97.5% |
| 12 Months | -78.9% | -87.4% | 46.4% |
| 5 Years | -65.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th40.00 | -6.37% | -7.15% |
| 3 Month | %th31.50 | -10.13% | -10.17% |
| 12 Month | %th4.50 | -87.31% | -90.06% |
| 5 Years | %th28.50 | -92.04% | -97.08% |
FAQs
Does Pliant Therapeutics (PLRX) outperform the market?
No,
over the last 12 months PLRX made -88.72%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months PLRX made 5.22%, while XBI made 17.08%.
Performance Comparison PLRX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
PLRX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 19% | -7.4% | -95.9% | -102% |
| US NASDAQ 100 | QQQ | 19.1% | -7.6% | -97.9% | -102% |
| German DAX 40 | DAX | 18.7% | -4.6% | -108% | -119% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 17.8% | -8% | -100.4% | -107% |
| Hongkong Hang Seng | HSI | 18.1% | -6.3% | -117.9% | -124% |
| India NIFTY 50 | INDA | 20.4% | -2.6% | -96.4% | -86% |
| Brasil Bovespa | EWZ | 23.2% | -2.8% | -111% | -90% |
PLRX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 20.4% | -5.1% | -99.2% | -113% |
| Consumer Discretionary | XLY | 18.1% | -6.8% | -88.2% | -107% |
| Consumer Staples | XLP | 21.1% | -3.3% | -95% | -96% |
| Energy | XLE | 16.1% | -7.6% | -88.4% | -91% |
| Financial | XLF | 20.5% | -6.1% | -98.2% | -114% |
| Health Care | XLV | 18.9% | -3.5% | -84.4% | -82% |
| Industrial | XLI | 18.6% | -7.9% | -101.8% | -112% |
| Materials | XLB | 18.4% | -7.9% | -96.6% | -93% |
| Real Estate | XLRE | 19.3% | -3.3% | -94.4% | -97% |
| Technology | XLK | 19.1% | -10.1% | -101% | -100% |
| Utilities | XLU | 19% | -6% | -100% | -109% |
| Aerospace & Defense | XAR | 18.4% | -10.3% | -115.9% | -138% |
| Biotech | XBI | 15.4% | -6.6% | -85.7% | -78% |
| Homebuilder | XHB | 16% | -12.2% | -89.3% | -88% |
| Retail | XRT | 19.1% | -6.7% | -91.1% | -95% |
PLRX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 18.4% | -6.72% | -82.0% | -84% |
| Natural Gas | UNG | 20.8% | 3% | -69.9% | -87% |
| Gold | GLD | 18.9% | -3.7% | -113.8% | -127% |
| Silver | SLV | 14.7% | -9.7% | -118% | -111% |
| Copper | CPER | 8.7% | -18.4% | -115.5% | -112% |
PLRX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 19.9% | -3.4% | -90.6% | -84% |
| iShares High Yield Corp. Bond | HYG | 19.6% | -4.6% | -92.9% | -98% |